left ventricular systolic dysfunction , LVSD (Abkürzung)

There is a strong association between left ventricular systolic dysfunction and heart failure.

Patients with left ventricular systolic dysfunction should be offered some type of exercise program.

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction.

Medical treatment for heart failure secondary to left ventricular systolic dysfunction is highly effective and may reduce mortality rate by over 50%.

During an average follow-up period of 8.6 years, left ventricular systolic dysfunction and cavity enlargement developed in the patients.

Cardiac toxicity was characterized as left ventricular systolic dysfunction; tachycardia may also occur.

Cardiac failure (left ventricular systolic dysfunction)

From clinical signs and an echocardiogram showing left ventricular systolic dysfunction, the diagnosis of systolic heart failure is made.

Although these findings are not specific to the diagnosis of heart failure a normal ECG virtually excludes left ventricular systolic dysfunction.

The records show that patients with left ventricular systolic dysfunction have been commenced on an angiotensin converting enzyme inhibitor unless there are contraindications 5.

Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction: insights from the National Heart Care Project.

National patterns of use and effectiveness of angiotensin converting enzyme inhibitors in older patients hospitalized with heart failure and left ventricular systolic dysfunction.

Key words: carvedilol, ischemic left ventricular systolic dysfunction, left ventricular ejection fraction, heart failure, left ventricular remodeling.

It was concluded that patients who have echocardiographic signs of left ventricular systolic dysfunction three to seven days after a myocardial infarction may be candidates for long-term treatment with trandolapril.

Liu) - The long-term mortality effects of ACE inhibition in patients with left ventricular systolic dysfunction: A ten-year follow-up of SOLVD trial.

This is because it is the cause of the heart failure that determines which treatment is correct e.g. surgery for valve disease, angiotensin converting enzyme (ACE) inhibitor for left ventricular systolic dysfunction.

ACE Inhibitors for Secondary Prevention after Acute Myocardial Infarction in Medicare Beneficiaries with Left Ventricular Systolic Dysfunction: Cooperative Cardiovascular Pilot Project.

However, current guidelines recommend β-blocker therapy for patients with systolic heart failure due to left ventricular systolic dysfunction after stabilization with diuretic and ACEI therapy, irrespective of symptomatic severity or blood pressure.

According to a meta-analysis comparing BNP and N-terminal pro-BNP (NTproBNP) in the diagnosis of heart failure, BNP is a better indicator for heart failure and left ventricular systolic dysfunction.

In 2009, NI Medical, a biotech company located in Kfar Malal, received approval by the U.S. Food and Drug Administration (FDA) for a device that assesses left ventricular systolic dysfunction (LVSD).

Based on the approval of CCM devices, cardiac contractility modulation is a treatment option for patients that are at least 18 years old who suffer from heart failure symptoms due to left ventricular systolic dysfunction (LVSD) despite adequate medical treatment.

Second, patients with Q-wave myocardial infarction were not eligible for enrollment because it was felt that statins would not influence the development of important prognostic determinants such as left ventricular systolic dysfunction, ventricular arrhythmias or mechanical complications [ 5 ] .

Though many issues remain to be resolved, data from the SOLVD prevention and SAVE trials provide compelling evidence that patients recovering from myocardial infarction with asymptomatic left ventricular systolic dysfunction (ejection fraction equal to or less than 40%) benefit from long term administration of an angiotensin converting enzyme inhibitor.

Dronedarone should not be given to patients with left ventricular systolic dysfunction, or to patients with current or previous episodes of heart failure.